跳至主要内容
临床试验/NCT04826887
NCT04826887已完成不适用

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

University of Kansas Medical Center1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2021年4月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Comparing the SOLTIVE Thulium Fiber to the Holmium Laser for HoLEP

研究概览

简要总结

To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP) vs Holmium Laser Enucleation of the Prostate.

Our hypothesis is that utilizing the SOLTIVE Thulium laser enucleation of the prostate will result in a more efficient procedure, comparable results to that of Holmium laser enucleation of the prostate and subjective improvement of prior device limitations

详细描述

Thulium laser is continuous wave laser which offers numerous potential benefits compared to alternative lasers and surgical procedures used for BPH. The SOLTIVE Laser system is a compact system which is significantly smaller than Holmium laser systems. The laser fiber is also smaller in diameter allowing for improved maneuverability with decreased fiber degradation and endoscope damage. The continuous wave pattern produces fast, hemostatic cuts during the removal and furthermore the associated hemostasis improves the visual field. Additionally, based on the 1940nm wavelength is absorbed nearly five times more in water. For all the stated reasons, the SOLTIVE Thulium Laser should improve the enucleation efficiency and warrants further investigation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients must be 18 years of age or older
  • Patients must be diagnosed with benign prostatic hyperplasia
  • Patients must opt for surgical management of their BPH with laser enucleation

排除标准

  • Patients with a concomitant neurogenic bladder diagnosis (SCI, Parkinson, MS, cerebral palsy)
  • Patients with prostate glands greater or equal to 200 grams
  • Patients who are enrolled in other surgical or interventional trials at the time of this study are not eligible.

结局指标

主要结局

Comparing the SOLTIVE Thulium Fiber to the Holmium Laser for HoLEP

时间窗: up to 1 year

To evaluate SOLTIVE Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP) in comparison to Holmium Laser Enucleation of the Prostate through AUA Symptom Score. AUA Symptom score will be assessed using the Scale - Mild (under 7 cumulative score, moderate 8-19 score, and severe is a cumulative score over 20).

次要结局

  • Compare intraoperative components between the two surgical approaches(up to 1 year)
  • Compare post-operative outcomes of the two surgical approaches(up to 2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Don Neff, MD, FACS

Principle Investigator

University of Kansas Medical Center

研究点 (1)

Loading locations...

相似试验